ArticleInternational journal of chronic obstructive pulmonary disease2025
Association Between Body Roundness Index and Chronic Obstructive Pulmonary Disease in US Adults: Data from NHANES 2013-2018.
Article in International journal of chronic obstructive pulmonary disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Global Research Trends in Comorbidity Between Chronic Obstructive Pulmonary Disease and Gastro-Oesophageal Reflux Disease: A Bibliometric Study.International journal of chronic obstructive pulmonary disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The association between the body roundness index (BRI) and the prevalence of chronic obstructive pulmonary disease (COPD) in US adults remains unclear. This study aims to investigate the association between BRI and the likelihood of developing COPD. Methods: This study was conducted based on data from the 2013-2018 National Health and Nutrition Examination Survey. Participants were classified as having COPD if they met any of the following criteria: (i) self-reported physician diagnosis of COPD; (ii) physician-confirmed diagnosis of emphysema; or (iii) physician-confirmed diagnosis of chronic bronchitis. Those who responded "no" to all of the above were categorized as non-COPD. To assess the association between BRI and COPD, weighted logistic regression models, subgroup analyses, and interaction tests were employed. The dose-response relationship was investigated using a restricted cubic spline (RCS) model. Results: A total of 14,254 individuals were included. The overall weighted prevalence of COPD was 8.3%. After adjusting for multiple confounders, continuous BRI was found to be positively associated with COPD (odds ratio [OR] = 1.140, 95% confidence interval [CI]: 1.033-1.259, P = 0.012). The RCS analysis confirmed a linear dose-response relationship between BRI and COPD. Subgroup analyses demonstrated substantial heterogeneity across sex, hypertension, and cardiovascular disease subgroups, indicating that the association between BRI and COPD may be impacted by these factors. Conclusion: Higher BRI levels were positively associated with an increased likelihood of developing COPD among US adults. Our study suggests that BRI holds promise as a tool for assessing the odds of having COPD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.